DocGo Inc.
DCGONasdaqHealthcare · Services-Health Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $322.2M | $616.6M | $624.3M | $440.5M | $318.7M | $94.1M |
| Operating income | −$178.0M | $28.7M | $15.1M | $21.8M | $15.4M | −$14.8M |
| Net income | −$182.4M | $20.0M | $6.9M | $34.6M | $23.7M | −$14.8M |
| Total assets | $217.1M | $455.6M | $490.5M | $393.3M | $309.6M | $100.2M |
| Total liabilities | $91.2M | $140.4M | $185.3M | $114.4M | $82.5M | $33.2M |
| Equity | $144.0M | $320.9M | $300.8M | $273.2M | $219.6M | $55.0M |
| EPS (diluted) | $-1.84 | $0.18 | $0.06 | $0.34 | $0.25 | $-0.25 |
| Shares out. | 102.0M | 104.2M | 102.5M | 100.2M | 100.1M | 76.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −55.3%
- Net margin
- −56.6%
- Return on equity
- −126.7%
- Return on assets
- −84.0%
- Return on capital (ROCE)
- −119.0%
- Liabilities / assets
- 42.0%
- Debt / equity
- 0.63×
- Book value / share
- $1.41
- Revenue growth (YoY)
- −47.7%
- Net income growth (YoY)
- −1012.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -4.05distress
- Accruals / assets
- −99.9%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 13, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 26, 2026
- Vashovsky StanleyActivist (13D)Feb 26, 2026
- Flynn James EPassive (13G)Feb 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.7M | 8.5 | -3.6% |
| Apr 30, 2026 | 4.9M | 5.1 | -24.1% |
| Apr 15, 2026 | 6.4M | 4.3 | +16.5% |
| Mar 31, 2026 | 5.5M | 3.6 | -7.1% |
| Mar 13, 2026 | 5.9M | 7.9 | +1.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 11, 2026
- Director / officer changeApr 22, 2026
- Results of operationsMar 16, 2026
- Delisting / listing-standard noticeJan 30, 2026
- Regulation FD disclosureDec 12, 2025
- Results of operationsNov 10, 2025
- Entered a material agreement · Regulation FD disclosureOct 20, 2025
- Results of operationsAug 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4FORM 4May 14, 2026
- 10-QMay 11, 2026
- 8-KMay 11, 2026
- ARSApr 22, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 22, 2026
- DEF 14APROXY STATEMENTApr 22, 2026
- 8-KApr 22, 2026
- PRE 14APROXY STATEMENTApr 10, 2026
- 4FORM 4Mar 31, 2026
- SCHEDULE 13G/AMar 26, 2026
- S-8Mar 17, 2026
- 10-KMar 16, 2026
- 8-KMar 16, 2026
- SCHEDULE 13D/AFeb 26, 2026
- 8-KJan 30, 2026
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.